Vanguard Group Inc Medicinova Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Medicinova Inc stock. As of the latest transaction made, Vanguard Group Inc holds 623,333 shares of MNOV stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
623,333
Previous 623,333
-0.0%
Holding current value
$1.02 Million
Previous $1.31 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MNOV
# of Institutions
29Shares Held
5.13MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.81 Million0.54% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA515KShares$844,4580.0% of portfolio
-
Citigroup Inc502KShares$823,2090.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA251KShares$412,2630.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $80.4M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...